QQQ   424.90 (-0.22%)
AAPL   167.64 (-0.21%)
MSFT   408.36 (-0.84%)
META   502.67 (+1.72%)
GOOGL   154.90 (-0.37%)
AMZN   180.38 (-0.50%)
TSLA   149.64 (-3.74%)
NVDA   843.44 (+0.37%)
AMD   154.22 (+0.13%)
NIO   3.92 (+0.26%)
BABA   69.16 (+0.49%)
T   16.14 (+0.12%)
F   12.09 (+0.42%)
MU   116.70 (+0.32%)
GE   157.07 (+0.90%)
CGC   6.53 (+0.62%)
DIS   112.95 (+0.01%)
AMC   2.80 (-6.04%)
PFE   25.45 (+0.12%)
PYPL   63.28 (+0.03%)
XOM   118.95 (+0.27%)
QQQ   424.90 (-0.22%)
AAPL   167.64 (-0.21%)
MSFT   408.36 (-0.84%)
META   502.67 (+1.72%)
GOOGL   154.90 (-0.37%)
AMZN   180.38 (-0.50%)
TSLA   149.64 (-3.74%)
NVDA   843.44 (+0.37%)
AMD   154.22 (+0.13%)
NIO   3.92 (+0.26%)
BABA   69.16 (+0.49%)
T   16.14 (+0.12%)
F   12.09 (+0.42%)
MU   116.70 (+0.32%)
GE   157.07 (+0.90%)
CGC   6.53 (+0.62%)
DIS   112.95 (+0.01%)
AMC   2.80 (-6.04%)
PFE   25.45 (+0.12%)
PYPL   63.28 (+0.03%)
XOM   118.95 (+0.27%)
QQQ   424.90 (-0.22%)
AAPL   167.64 (-0.21%)
MSFT   408.36 (-0.84%)
META   502.67 (+1.72%)
GOOGL   154.90 (-0.37%)
AMZN   180.38 (-0.50%)
TSLA   149.64 (-3.74%)
NVDA   843.44 (+0.37%)
AMD   154.22 (+0.13%)
NIO   3.92 (+0.26%)
BABA   69.16 (+0.49%)
T   16.14 (+0.12%)
F   12.09 (+0.42%)
MU   116.70 (+0.32%)
GE   157.07 (+0.90%)
CGC   6.53 (+0.62%)
DIS   112.95 (+0.01%)
AMC   2.80 (-6.04%)
PFE   25.45 (+0.12%)
PYPL   63.28 (+0.03%)
XOM   118.95 (+0.27%)
QQQ   424.90 (-0.22%)
AAPL   167.64 (-0.21%)
MSFT   408.36 (-0.84%)
META   502.67 (+1.72%)
GOOGL   154.90 (-0.37%)
AMZN   180.38 (-0.50%)
TSLA   149.64 (-3.74%)
NVDA   843.44 (+0.37%)
AMD   154.22 (+0.13%)
NIO   3.92 (+0.26%)
BABA   69.16 (+0.49%)
T   16.14 (+0.12%)
F   12.09 (+0.42%)
MU   116.70 (+0.32%)
GE   157.07 (+0.90%)
CGC   6.53 (+0.62%)
DIS   112.95 (+0.01%)
AMC   2.80 (-6.04%)
PFE   25.45 (+0.12%)
PYPL   63.28 (+0.03%)
XOM   118.95 (+0.27%)
Free Trial

Enanta Pharmaceuticals (ENTA) Earnings Date, Estimates & Call Transcripts

→ Don’t expose yourself to stocks during the week (From DTI) (Ad)
Free ENTA Stock Alerts
$13.51
-0.49 (-3.50%)
(As of 09:57 AM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Earnings Summary

Upcoming
Earnings Date
May. 13Estimated
Actual EPS
(Feb. 7)
-$1.58 Missed By -$0.40
Consensus EPS
(Feb. 7)
-$1.18
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

ENTA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ENTA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Enanta Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20242($2.32)($1.35)($1.84) 
Q2 20242($2.63)($1.31)($1.97) 
Q3 20242($1.46)($0.91)($1.19) 
Q4 20242($1.05)($0.72)($0.89) 
FY 20248($7.46)($4.29) ($5.88)

ENTA Earnings Date and Information

Enanta Pharmaceuticals last posted its quarterly earnings results on February 7th, 2024. The biotechnology company reported ($1.58) earnings per share for the quarter, missing analysts' consensus estimates of ($1.18) by $0.40. The company earned $18 million during the quarter, compared to analyst estimates of $22.74 million. Enanta Pharmaceuticals has generated ($6.56) earnings per share over the last year (($6.56) diluted earnings per share). Earnings for Enanta Pharmaceuticals are expected to grow in the coming year, from ($4.90) to ($4.55) per share. Enanta Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 13th, 2024 based off prior year's report dates.

Enanta Pharmaceuticals Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/13/2024
Estimated)		------- 
2/7/2024Q1 2024($1.18)($1.58)($0.40)($1.58)$22.74 million$18.00 million
11/20/2023Q3 2023($2.11)($1.33)+$0.78($1.33)$17.93 million$18.93 million    
8/7/2023Q3 2023($2.38)($1.86)+$0.52($1.86)$15.88 million$18.89 million
5/8/2023Q2 2023($1.91)($1.79)+$0.12($1.79)$19.06 million$17.80 million    
2/7/2023Q1 2023($1.52)($1.39)+$0.13($1.39)$22.48 million$23.60 million    
11/21/2022Q4 2022($1.37)($1.27)+$0.10($1.27)$22.86 million$20.32 million    
8/8/2022Q3 2022($1.36)($1.53)($0.17)($1.53)$20.73 million$19.48 million    
5/9/2022Q2 2022($1.43)($1.63)($0.20)($1.63)$20.40 million$18.72 million    
2/8/2022Q1 2022($1.13)($1.48)($0.35)($1.48)$26.34 million$27.60 million    
11/22/2021Q3 2021($1.31)($1.22)+$0.09($1.22)$35.65 million$23.58 million    
8/5/2021Q2 2021($1.41)($1.19)+$0.22($1.19)$21.87 million$21.62 million  
5/6/2021Q1 2021($0.94)($1.09)($0.15)($1.09)$25.05 million$20.10 million  

Enanta Pharmaceuticals Earnings - Frequently Asked Questions

When is Enanta Pharmaceuticals's earnings date?

Enanta Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 13th, 2024 based off last year's report dates. Learn more on ENTA's earnings history.

Did Enanta Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, Enanta Pharmaceuticals (NASDAQ:ENTA) missed the analysts' consensus estimate of ($1.18) by $0.40 with a reported earnings per share (EPS) of ($1.58). Learn more on analysts' earnings estimate vs. ENTA's actual earnings.

How much revenue does Enanta Pharmaceuticals generate each year?

Enanta Pharmaceuticals (NASDAQ:ENTA) has a recorded annual revenue of $79.20 million.

How much profit does Enanta Pharmaceuticals generate each year?

Enanta Pharmaceuticals (NASDAQ:ENTA) has a recorded net income of -$133.82 million. ENTA has generated -$6.56 earnings per share over the last four quarters.

What is Enanta Pharmaceuticals's EPS forecast for next year?

Enanta Pharmaceuticals's earnings are expected to grow from ($4.90) per share to ($4.55) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:ENTA) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
[Urgent!] Generational Wealth Gameplan
Crypto 101 Media
He Is Giving Away Bitcoin
Crypto Swap Profits
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
Biden out June 13; Kamala won’t replace him?
Paradigm Press
Top 5 Tech Stocks to Buy for 2024
Daily Market Alerts
Urgent alert: open this for a huge profit potential
Timothy Sykes
Options trading has suddenly become more reliable.
Eagle Publishing
The Next Nvidia?
InvestorPlace